SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-24-005485
Filing Date
2024-09-12
Accepted
2024-09-12 16:31:12
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6410
  Complete submission text file 0000902664-24-005485.txt   8392
Mailing Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017 718-570-6018
Caligan Partners LP (Reporting) CIK: 0001727492 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39724 | Film No.: 241295346

Mailing Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address
JOHNSON DAVID EDWARD (Reporting) CIK: 0001785557 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39724 | Film No.: 241295345

Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Issuer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)